Trial of Ipilimumab After Isolated Limb Perfusion, in Patients With Metastases Melanoma

NCT02094391 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

In-transit Metastases Melanoma Stage IIIB and IIIC

Interventions

DRUG: Ipilimumab

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris